Dysregulation and Diagnostic Potential of microRNA in Alzheimer's Disease

Journal of Alzheimer's Disease

Volumn 49, Issue 1, 2015, Pages 1-12

  Pan, Yaoqian ^a   Liu, Ruizhu ^e   Terpstra, Erin ^b   Wang, Yanqing ^b   Qiao, Fangfang ^b   Wang, Jin ^c,d   Tong, Yigang ^c   Pan, Bo ^a  

^a HENAN INSTITUTE OF SCIENCE AND TECHNOLOGY   (China)

^b UNIVERSITY OF SOUTH DAKOTA   (United States)

^c BEIJING INSTITUTE OF MICROBIOLOGY AND EPIDEMIOLOGY   (China)

^d CHINA AGRICULTURAL UNIVERSITY   (China)

^e JILIN UNIVERSITY   (China)

Author keywords

Alzheimer's disease; biomarkers; microRNAs

Indexed keywords

AMYLOID PROTEIN; BIOLOGICAL MARKER; MICRORNA; MICRORNA 101; MICRORNA 124; MICRORNA 125B; MICRORNA 128; MICRORNA 132; MICRORNA 219; MICRORNA 9; UNCLASSIFIED DRUG;

ALTERNATIVE RNA SPLICING; ALZHEIMER DISEASE; AXONAL INJURY; BLOOD ANALYSIS; CEREBROSPINAL FLUID ANALYSIS; DEGENERATIVE DISEASE; DISEASE ASSOCIATION; EXTRACELLULAR MATRIX; HUMAN; INFLAMMATION; MOLECULAR PATHOLOGY; NERVE CELL NECROSIS; NEUROFIBRILLARY TANGLE; NEUROPATHOLOGY; NEXT GENERATION SEQUENCING; NONHUMAN; PRIORITY JOURNAL; PROTEIN AGGREGATION; REGULATORY MECHANISM; REVIEW; RNA ANALYSIS; RNA SEQUENCE; AGED; BLOOD; CEREBROSPINAL FLUID; DISEASE COURSE; GENETICS; PROGNOSIS;

AGED; ALZHEIMER DISEASE; BIOMARKERS; DISEASE PROGRESSION; HUMANS; MICRORNAS; PROGNOSIS;

EID: 84948656562     PISSN: 13872877     EISSN: 18758908     Source Type: Journal    
DOI: 10.3233/JAD-150451     Document Type: Review

References (134)

1. Hebert LE, Scherr PA, Bienias JL, Bennett DA, Evans DA (2003) Alzheimer disease in the US population: Prevalence estimates using the 2000 census. Arch Neurol 60, 1119-1122.
2. Plassman BL, Langa KM, Fisher GG, Heeringa SG, Weir DR, Ofstedal MB, Burke JR, Hurd MD, Potter GG, Rodgers WL, Steffens DC, Willis RJ, Wallace RB (2007) Prevalence of dementia in the United States: The Aging, Demographics, and Memory Study. Neuroepidemiology 29, 125-132.
3. Humpel C (2011) Identifying and validating biomarkers for Alzheimer's disease. Trends Biotechnol 29, 26-32.
4. Lukiw WJ, Andreeva TV, Grigorenko AP, Rogaev EI (2012) Studying micro RNA function and dysfunction in Alzheimer's disease. Front Genet 3, 327.
5. Choi YS, Choe LH, Lee KH (2010) Recent cerebrospinal fluid biomarker studies of Alzheimer's disease. Expert Rev Proteomics 7, 919-929.
6. Selkoe DJ (2004) Cell biology of protein misfolding: The examples of Alzheimer's and Parkinson's diseases. Nat Cell Biol 6, 1054-1061.
7. Morris JC (1997) The challenge of characterizing normal brain aging in relation to Alzheimer's disease. Neurobiol Aging 18, 388-389, 389-392.
8. Morris JC, Price JL (2001) Pathologic correlates of nondemented aging, mild cognitive impairment, and early-stage Alzheimer's disease. J Mol Neurosci 17, 101-118.
9. Braak H, Braak E, Bohl J (1993) Staging of Alzheimerrelated cortical destruction. Eur Neurol 33, 403-408.
10. Squire LR (1992) Memory and the hippocampus: A synthesis from findings with rats, monkeys, and humans. Psychol Rev 99, 195-231.
11. Sahay A, Scobie KN, Hill AS, O'Carroll CM, Kheirbek MA, Burghardt NS, Fenton AA, Dranovsky A, Hen R (2011) Increasing adult hippocampal neurogenesis is sufficient to improve pattern separation. Nature 472, 466-470.
12. Gomez-Isla T, Price JL, McKeel DJ, Morris JC, Growdon JH, Hyman BT (1996) Profound loss of layer II entorhinal cortex neurons occurs in very mild Alzheimer's disease. J Neurosci 16, 4491-4500.
13. Walhovd KB, Fjell AM, Brewer J, McEvoy LK, Fennema-Notestine C, Hagler DJ, Jennings RG, Karow D, Dale AM (2010) Combining MR imaging, positron-emission tomography, and CSF biomarkers in the diagnosis and prognosis of Alzheimer disease. AJNR Am J Neuroradiol 31, 347-354.
14. Ambros V (2004) The functions of animal microRNAs. Nature 431, 350-355.
15. Bartel DP (2004) MicroRNAs: Genomics, biogenesis, mechanism, and function. Cell 116, 281-297.
16. He L, Hannon GJ (2004) MicroRNAs: Small RNAs with a big role in gene regulation. Nat Rev Genet 5, 522-531.
17. Kosik KS (2006) The neuronal microRNA system. Nat Rev Neurosci 7, 911-920.
18. Sood P, Krek A, Zavolan M, Macino G, Rajewsky N (2006) Cell-type-specific signatures of microRNAs on target mRNA expression. Proc Natl Acad Sci USA 103, 2746-2751.
19. Baek D, Villen J, Shin C, Camargo FD, Gygi SP, Bartel DP (2008) The impact of microRNAs on protein output. Nature 455, 64-71.
20. Beuvink I, Kolb FA, Budach W, Garnier A, Lange J, Natt F, Dengler U, Hall J, Filipowicz W, Weiler J (2007) A novel microarray approach reveals new tissue-specific signatures of known and predicted mammalian microRNAs. Nucleic Acids Res 35, e52:1-11.
21. Landgraf P, Rusu M, Sheridan R, Sewer A, Iovino N, Aravin A, Pfeffer S, Rice A, Kamphorst AO, Landthaler M, Lin C, Socci ND, Hermida L, Fulci V, Chiaretti S, Foa R, Schliwka J, Fuchs U, Novosel A, Muller RU, Schermer B, Bissels U, Inman J, Phan Q, Chien M, Weir DB, Choksi R, De Vita G, Frezzetti D, Trompeter HI, Hornung V, Teng G, Hartmann G, Palkovits M, Di Lauro R, Wernet P, Macino G, Rogler CE, Nagle JW, Ju J, Papavasiliou FN, Benzing T, Lichter P, Tam W, Brownstein MJ, Bosio A, Borkhardt A, Russo JJ, Sander C, Zavolan M, Tuschl T (2007) A mammalian microRNA expression atlas based on small RNA library sequencing. Cell 129, 1401-1414.
22. Castellano L, Stebbing J (2013) Deep sequencing of small RNAs identifies canonical and non-canonical miRNA and endogenous siRNAs in mammalian somatic tissues. Nucleic Acids Res 41, 3339-3351.
23. Li YY, Alexandrov PN, Pogue AI, Zhao Y, Bhattacharjee S, Lukiw WJ (2012) miRNA-155 upregulation and complement factorHdeficits in Down's syndrome. Neuroreport 23, 168-173.
24. Sethi P, Lukiw WJ (2009) Micro-RNA abundance and stability in human brain: Specific alterations in Alzheimer's disease temporal lobe neocortex. Neurosci Lett 459, 100-104.
25. Burmistrova OA, Goltsov AY, Abramova LI, Kaleda VG, Orlova VA, Rogaev EI (2007) MicroRNA in schizophrenia: Genetic and expression analysis of miR-130b (22q11). Biochemistry (Mosc) 72, 578-582.
26. Pogue AI, Li YY, Cui JG, Zhao Y, Kruck TP, Percy ME, Tarr MA, Lukiw WJ (2009) Characterization of an NF-kappaB-regulated, miRNA-146a-mediated down-regulation of complement factor H (CFH) in metalsulfate-stressed human brain cells. J Inorg Biochem 103, 1591-1595.
27. Wang K, Zhang S, Weber J, Baxter D, Galas DJ (2010) Export of microRNAs and microRNA-protective protein by mammalian cells. Nucleic Acids Res 38, 7248-7259.
28. Kim J, Inoue K, Ishii J, Vanti WB, Voronov SV, Murchison E, Hannon G, Abeliovich A (2007) A MicroRNA feedback circuit in midbrain dopamine neurons. Science 317, 1220-1224.
29. Saba R, Goodman CD, Huzarewich RL, Robertson C, Booth SA (2008) A miRNA signature of prion induced neurodegeneration. PLoS One 3, e3652.
30. Lukiw WJ, Pogue AI (2007) Induction of specific micro RNA (miRNA) species by ROS-generating metal sulfates in primary human brain cells. J Inorg Biochem 101, 1265-1269.
31. Lukiw WJ (2007) Micro-RNA speciation in fetal, adult and Alzheimer's disease hippocampus. Neuroreport 18, 297-300.
32. Cogswell JP, Ward J, Taylor IA, Waters M, Shi Y, Cannon B, Kelnar K, Kemppainen J, Brown D, Chen C, Prinjha RK, Richardson JC, Saunders AM, Roses AD, Richards CA (2008) Identification of miRNAchanges in Alzheimer's disease brain and CSF yields putative biomarkers and insights into disease pathways. J Alzheimers Dis 14, 27-41.
33. Hebert SS, Horre K, Nicolai L, Bergmans B, Papadopoulou AS, Delacourte A, De Strooper B (2009) MicroRNAregulation of Alzheimer's Amyloid precursor protein expression. Neurobiol Dis 33, 422-428.
34. Van den Hove DL, Kompotis K, Lardenoije R ,Kenis G, Mill J, Steinbusch HW, Lesch KP, Fitzsimons CP, De Strooper B, Rutten BP (2014) Epigenetically regulated microRNAs in Alzheimer's disease. Neurobiol Aging 35, 731-745.
35. Bennett DA, Yu L, Yang J, Srivastava GP, Aubin C, De Jager PL (2015) Epigenomics of Alzheimer's disease. Transl Res 165, 200-220.
36. Wang WX, Rajeev BW, Stromberg AJ, Ren N, Tang G, Huang Q, Rigoutsos I, Nelson PT (2008) The expression of microRNA miR-107 decreases early in Alzheimer's disease and may accelerate disease progression through regulation of beta-site amyloid precursor protein-cleaving enzyme 1. J Neurosci 28, 1213-1223.
37. Boissonneault V, Plante I, Rivest S, Provost P (2009) MicroRNA-298 and microRNA-328 regulate expression of mouse beta-amyloid precursor protein-converting enzyme 1. J Biol Chem 284, 1971-1981.
38. Long JM, Lahiri DK (2011) MicroRNA-101 downregulates Alzheimer's amyloid-beta precursor protein levels in human cell cultures and is differentially expressed. Biochem Biophys Res Commun 404, 889-895.
39. Delay C, Calon F, Mathews P, Hebert SS (2011) Alzheimerspecific variants in the 3'UTR of Amyloid precursor protein affect microRNA function. Mol Neurodegener 6, 70.
40. Bahr BA, Wisniewski ML, Butler D (2012) Positive lysosomal modulation as a unique strategy to treat agerelated protein accumulation diseases. Rejuvenation Res 15, 189-197.
41. Tiribuzi R, Crispoltoni L, Porcellati S, Di Lullo M, Florenzano F, Pirro M, Bagaglia F, Kawarai T, Zampolini M, Orlacchio A, Orlacchio A(2014) miR128 up-regulation correlates with impaired amyloid beta(1-42) degradation in monocytes from patients with sporadic Alzheimer's disease. Neurobiol Aging 35, 345-356.
42. Schonrock N, Matamales M, Ittner LM, Götz J (2012) MicroRNA networks surrounding APP and amyloid-metabolism-Implications for Alzheimer's disease. Exp Neurol 235, 447-454.
43. Smith P, Al HA, Girard J, Delay C, Hebert SS (2011) In vivo regulation of amyloid precursor protein neuronal splicing by microRNAs. J Neurochem 116, 240-247.
44. Shioya M, Obayashi S, Tabunoki H, Arima K, Saito Y, Ishida T, Satoh J (2010) Aberrant microRNA expression in the brains of neurodegenerative diseases: miR-29a decreased in Alzheimer disease brains targets neurone navigator 3. Neuropathol Appl Neurobiol 36, 320-330.
45. Zetterberg H, Blennow K, Hanse E (2010) Amyloid beta and APP as biomarkers for Alzheimer's disease. Exp Gerontol 45, 23-29.
46. Stefani A, Bernardini S, Panella M, Pierantozzi M, Nuccetelli M, Koch G, Urbani A, Giordano A, Martorana A, Orlacchio A, Federici G, Bernardi G (2005) AD with subcortical white matter lesions and vascular dementia: CSF markers for differential diagnosis. J Neurol Sci 237, 83-88.
47. Vassar R, Bennett BD, Babu-Khan S, Kahn S, Mendiaz EA, Denis P, Teplow DB, Ross S, Amarante P, Loeloff R, Luo Y, Fisher S, Fuller J, Edenson S, Lile J, Jarosinski MA, Biere AL, Curran E, Burgess T, Louis JC, Collins F, Treanor J, Rogers G, Citron M (1999) Beta-secretase cleavage of Alzheimer's amyloid precursor protein by the transmembrane aspartic protease BACE. Science 286, 735-741.
48. Magen I, Hornstein E (2014) Oligonucleotide-based therapy for neurodegenerative diseases. Brain Res 1584, 116-128.
49. Hampel H, Shen Y (2009) Beta-site amyloid precursor protein cleaving enzyme 1 (BACE1) as a biological candidate marker of Alzheimer's disease. Scand J Clin Lab Invest 69, 8-12.
50. Zetterberg H, Andreasson U, Hansson O, Wu G, Sankaranarayanan S, Andersson ME, Buchhave P, Londos E, Umek RM, Minthon L, Simon AJ, Blennow K (2008) Elevated cerebrospinal fluid BACE1 activity in incipient Alzheimer disease. Arch Neurol 65, 1102-1107.
51. Deng Y, Ding Y, Hou D (2014) Research status of the regulation of miRNA on BACE1. Int J Neurosci 124, 474-477.
52. Hebert SS, Horre K, Nicolai L, Papadopoulou AS, Mandemakers W, Silahtaroglu AN, Kauppinen S, Delacourte A, De Strooper B (2008) Loss of microRNA cluster miR-29a/b-1 in sporadic Alzheimer's disease correlates with increased BACE1/beta-secretase expression. Proc Natl Acad Sci USA 105, 6415-6420.
53. Zong Y, Wang H, Dong W, Quan X, Zhu H, Xu Y, Huang L, Ma C, Qin C (2011) miR-29c regulates BACE1 protein expression. Brain Res 1395, 108-115.
54. Wang LL, Huang Y, Wang G, Chen SD (2012) The potential role of microRNA-146 in Alzheimer's disease: Biomarker or therapeutic target Med Hypotheses 78, 398-401.
55. Geekiyanage H, Chan C (2011) MicroRNA-137/181c regulates serine palmitoyltransferase and in turn amyloid beta, novel targets in sporadic Alzheimer's disease. J Neurosci 31, 14820-14830.
56. Codocedo JF, Rios JA, Godoy JA, Inestrosa NC (2015) Are microRNAs the molecular link between metabolic syndrome and Alzheimer's disease Mol Neurobiol. doi: 10.1007/s12035-015-9201-7.
57. Du T, Zamore PD (2005) microPrimer: The biogenesis and function of microRNA. Development 132, 4645-4652.
58. Goedert M (1993) Tau protein and the neurofibrillary pathology of Alzheimer's disease. Trends Neurosci 16, 460-465.
59. Carrettiero DC, Hernandez I, Neveu P, Papagiannakopoulos T, Kosik KS (2009) The cochaperone BAG2 sweeps paired helical filament-insoluble tau from the microtubule. J Neurosci 29, 2151-2161.
60. Hebert SS, Sergeant N, Buee L (2012) MicroRNAs and the regulation of tau metabolism. Int J Alzheimers Dis 2012, 406561.
61. Smith PY, Delay C, Girard J, Papon MA, Planel E, Sergeant N, Buee L, Hebert SS (2011) MicroRNA-132 loss is associated with tau exon 10 inclusion in progressive supranuclear palsy. Hum Mol Genet 20, 4016-4024.
62. Dickson JR, Kruse C, Montagna DR, Finsen B, Wolfe MS (2013) Alternative polyadenylation and miR-34 family members regulate tau expression. J Neurochem 127, 739-749.
63. Julien C, Tremblay C, Emond V, Lebbadi M, Salem NJ, Bennett DA, Calon F (2009) Sirtuin 1 reduction parallels the accumulation of tau in Alzheimer disease. J Neuropathol Exp Neurol 68, 48-58.
64. Ramachandran D, Roy U, Garg S, Ghosh S, Pathak S, Kolthur-Seetharam U (2011) Sirt1 and mir-9 expression is regulated during glucose-stimulated insulin secretion in pancreatic beta-islets. FEBS J 278, 1167-1174.
65. Wang X, Liu P, Zhu H, Xu Y, Ma C, Dai X, Huang L, Liu Y, Zhang L, Qin C (2009) miR-34a, a microRNA up-regulated in a double transgenic mouse model of Alzheimer's disease, inhibits bcl2 translation. Brain Res Bull 80, 268-273.
66. Zovoilis A, Agbemenyah HY, Agis-Balboa RC, Stilling RM, Edbauer D, Rao P, Farinelli L, Delalle I, Schmitt A, Falkai P, Bahari-Javan S, Burkhardt S, Sananbenesi F, Fischer A (2011) microRNA-34c is a novel target to treat dementias. EMBO J 30, 4299-4308.
67. Zhao ZB, Wu L, Xiong R, Wang LL, Zhang B, Wang C, Li H, Liang L, Chen SD (2014) MicroRNA-922 promotes tau phosphorylation by downregulating ubiquitin carboxy-terminal hydrolase L1 (UCHL1) expression in the pathogenesis of Alzheimer's disease. Neuroscience 275, 232-237.
68. Perry MM, Williams AE, Tsitsiou E, Larner-Svensson HM, Lindsay MA (2009) Divergent intracellular pathways regulate interleukin-1beta-induced miR-146a and miR-146b expression and chemokine release in human alveolar epithelial cells. FEBS Lett 583, 3349-3355.
69. Lukiw WJ, Zhao Y, Cui JG (2008) An NF-kappaBsensitive microRNA-146a-mediated inflammatory circuit in Alzheimer disease and in stressed human brain cells. J Biol Chem 283, 31315-31322.
70. Lukiw WJ, Alexandrov PN (2012) Regulation of complement factor H (CFH) by multiple miRNAs in Alzheimer's disease (AD) brain. Mol Neurobiol 46, 11-19.
71. Lukiw WJ, Alexandrov PN, Zhao Y, Hill JM, Bhattacharjee S (2012) Spreading of Alzheimer's disease inflammatory signaling through soluble micro-RNA. Neuroreport 23, 621-626.
72. Zhao Y, Bhattacharjee S, Jones BM, Hill J, Dua P, Lukiw WJ (2014) Regulation of neurotropic signaling by the inducible, NF-kB-sensitive miRNA-125b in Alzheimer's disease (AD) and in primary human neuronal-glial (HNG) cells. Mol Neurobiol 50, 97-106.
73. Olivieri F, Rippo MR, Procopio AD, Fazioli F (2013) Circulating inflamma-miRs in aging and age-related diseases. Front Genet 4, 121.
74. Lee JH, Cheon YH, Woo RS, Song DY, Moon C, Baik TK (2012) Evidence of early involvement of apoptosis inducing factor-induced neuronal death in Alzheimer brain. Anat Cell Biol 45, 26-37.
75. Cimmino A, Calin GA, Fabbri M, Iorio MV, Ferracin M, Shimizu M, Wojcik SE, Aqeilan RI, Zupo S, Dono M, Rassenti L, Alder H, Volinia S, Liu CG, Kipps TJ, Negrini M, Croce CM (2005) miR-15 and miR-16 induce apoptosis by targeting BCL2. Proc Natl Acad Sci USA 102, 13944-13949.
76. Fang M, Wang J, Zhang X, Geng Y, Hu Z, Rudd JA, Ling S, Chen W, Han S (2012) The miR-124 regulates the expression of BACE1/beta-secretase correlated with cell death in Alzheimer's disease. Toxicol Lett 209, 94-105.
77. Sun X, Wu Y, Gu M, Zhang Y (2014) miR-342-5p decreases ankyrin G levels in Alzheimer's disease transgenic mouse models. Cell Rep 6, 264-270.
78. Calin GA, Liu CG, Ferracin M, Hyslop T, Spizzo R, Sevignani C, Fabbri M, Cimmino A, Lee EJ, Wojcik SE, Shimizu M, Tili E, Rossi S, Taccioli C, Pichiorri F, Liu X, Zupo S, Herlea V, Gramantieri L, Lanza G, Alder H, Rassenti L, Volinia S, Schmittgen TD, Kipps TJ, Negrini M, Croce CM (2007) Ultraconserved regions encoding ncRNAs are altered in human leukemias and carcinomas. Cancer Cell 12, 215-229.
79. Marx J (2007) Alzheimer's disease. A new take on tau. Science 316, 1416-1417.
80. Craft S (2006) Insulin resistance syndrome and Alzheimer disease: Pathophysiologic mechanisms and therapeutic implications. Alzheimer Dis Assoc Disord 20, 298-301.
81. Fehlbaum-Beurdeley P, Sol O, Desire L, Touchon J, Dantoine T, Vercelletto M, Gabelle A, Jarrige AC, Haddad R, Lemarie JC, Zhou W, Hampel H, Einstein R, Vellas B (2012) Validation of AclarusDx, a blood-based transcriptomic signature for the diagnosis of Alzheimer's disease. J Alzheimers Dis 32, 169-181.
82. Xu XH, Huang Y, Wang G, Chen SD (2012) Metabolomics: Anovel approach to identify potential diagnostic biomarkers and pathogenesis in Alzheimer's disease. Neurosci Bull 28, 641-648.
83. Ishikawa M, Tajima Y, Murayama M, Senoo Y, Maekawa K, Saito Y (2013) Plasma and serum from nonfasting men and women differ in their lipidomic profiles. Biol Pharm Bull 36, 682-685.
84. Sheinerman KS, Umansky SR (2013) Early detection of neurodegenerative diseases: Circulating brain-enriched microRNA. Cell Cycle 12, 1-2.
85. Zandberga E, Kozirovskis V, Abols A, Andrejeva D, Purkalne G, Line A(2013) Cell-free microRNAs as diagnostic, prognostic, and predictive biomarkers for lung cancer. Genes Chromosomes Cancer 52, 356-369.
86. Qin LX, Tuschl T, Singer S (2013) An empirical evaluation of normalization methods for MicroRNA arrays in a liposarcoma study. Cancer Inform 12, 83-101.
87. Williams Z, Ben-Dov IZ, Elias R, Mihailovic A, Brown M, Rosenwaks Z, Tuschl T (2013) Comprehensive profiling of circulating microRNA via small RNA sequencing of cDNA libraries reveals biomarker potential and limitations. Proc Natl Acad Sci USA 110, 4255-4260.
88. Leidner RS, Li L, Thompson CL (2013) Dampening enthusiasm for circulating microRNA in breast cancer. PLoS One 8, e57841.
89. Boeri M, Verri C, Conte D, Roz L, Modena P, Facchinetti F, Calabro E, Croce CM, Pastorino U, Sozzi G (2011) MicroRNA signatures in tissues and plasma predict development and prognosis of computed tomography detected lung cancer. Proc Natl Acad Sci USA 108, 3713-3718.
90. Cuk K, Zucknick M, Heil J, Madhavan D, Schott S, Turchinovich A, Arlt D, Rath M, Sohn C, Benner A, Junkermann H, Schneeweiss A, Burwinkel B (2013) Circulating microRNAs in plasma as early detection markers for breast cancer. Int J Cancer 132, 1602-1612.
91. Sheinerman KS, Tsivinsky VG, Crawford F, Mullan MJ, Abdullah L, Umansky SR (2012) Plasma microRNA biomarkers for detection of mild cognitive impairment. Aging (Albany NY) 4, 590-605.
92. Meyer SU, Pfaffl MW, Ulbrich SE (2010) Normalization strategies for microRNA profiling experiments: A 'normal' way to a hidden layer of complexity Biotechnol Lett 32, 1777-1788.
93. Sarkar D, Parkin R, Wyman S, Bendoraite A, Sather C, Delrow J, Godwin AK, Drescher C, Huber W, Gentleman R, Tewari M (2009) Quality assessment and data analysis for microRNA expression arrays. Nucleic Acids Res 37, e17.
94. Kroh EM, Parkin RK, Mitchell PS, Tewari M (2010) Analysis of circulating microRNA biomarkers in plasma and serum using quantitative reverse transcription-PCR (qRTPCR). Methods 50, 298-301.
95. Peltier HJ, Latham GJ (2008) Normalization of microRNA expression levels in quantitative RT-PCR assays: Identification of suitable reference RNA targets in normal and cancerous human solid tissues. RNA 14, 844-852.
96. Latham GJ (2010) Normalization of microRNA quantitative RT-PCR data in reduced scale experimental designs. Methods Mol Biol 667, 19-31.
97. Sanders I, Holdenrieder S, Walgenbach-Brunagel G, von Ruecker A, Kristiansen G, Muller SC, Ellinger J (2012) Evaluation of reference genes for the analysis of serum miRNA in patients with prostate cancer, bladder cancer and renal cell carcinoma. Int J Urol 19, 1017-1025.
98. Kheirelseid EA, Miller N, Chang KH, Curran C, Hennessey E, Sheehan M, Newell J, Lemetre C, Balls G, Kerin MJ (2013) miRNA expressions in rectal cancer as predictors of response to neoadjuvant chemoradiation therapy. Int J Colorectal Dis 28, 247-260.
99. Matthaei H, Wylie D, Lloyd MB, Dal Molin M, Kemppainen J, Mayo SC, Wolfgang CL, Schulick RD, Langfield L, Andruss BF, Adai AT, Hruban RH, Szafranska-Schwarzbach AE, Maitra A (2012) miRNA biomarkers in cyst fluid augment the diagnosis and management of pancreatic cysts. Clin Cancer Res 18, 4713-4724.
100. Kim DH, Yeo SH, Park JM, Choi JY, Lee TH, Park SY, Ock MS, Eo J, Kim HS, Cha HJ (2014) Genetic markers for diagnosis and pathogenesis of Alzheimer's disease. Genet 545, 185-193.
101. Puglielli L, Tanzi RE, Kovacs DM (2003) Alzheimer's disease: The cholesterol connection. Nat Neurosci 6, 345-351.
102. Koturbash I, Zemp F, Kolb B, Kovalchuk O (2011) Sexspecific radiation-induced microRNAome responses in the hippocampus, cerebellum and frontal cortex in a mouse model. Mutat Res 722, 114-118.
103. Kiko T, Nakagawa K, Tsuduki T, Furukawa K, Arai H, Miyazawa T (2014) MicroRNAs in plasma and cerebrospinal fluid as potential markers for Alzheimer's disease. J Alzheimers Dis 39, 253-259.
104. Pogue AI, Hill JM, Lukiw WJ (2014) MicroRNA (miRNA): Sequence and stability, viroid-like properties, and disease association in the CNS. Brain Res 1584, 73-79.
105. Li X, Khanna A, Li N, Wang E (2011) Circulatory miR34a as an RNAbased, noninvasive biomarker for brain aging. Aging (Albany NY) 3, 985-1002.
106. Ferreiro E, Eufrasio A, Pereira C, Oliveira CR, Rego AC (2007) Bcl-2 overexpression protects against amyloid-beta and prion toxicity in GT1-7 neural cells. J Alzheimers Dis 12, 223-228.
107. Bhatnagar S, Chertkow H, Schipper HM, Yuan Z, Shetty V, Jenkins S, Jones T, Wang E(2014) Increased microRNA-34c abundance in Alzheimer's disease circulating blood plasma. Front Mol Neurosci 7, 2.
108. Muller M, Jakel L, Bruinsma IB, Claassen JA, Kuiperij HB, Verbeek MM (2015) MicroRNA-29a is a candidate biomarker for Alzheimer's disease in cell-free cerebrospinal fluid. Mol Neurobiol, doi: 10.1007/s12035-015-9156-8
109. Tan L, Yu JT, Tan L (2015) Causes and consequences of MicroRNA dysregulation in neurodegenerative diseases. Mol Neurobiol 51, 1249-1262.
110. Galimberti D, Villa C, Fenoglio C, Serpente M, Ghezzi L, Cioffi SM, Arighi A, Fumagalli G, Scarpini E (2014) Circulating miRNAs as potential biomarkers in Alzheimer's disease. J Alzheimers Dis 42, 1261-1267.
111. Sala FC, Lau P, Salta E, Tournoy J, Bossers K, Vandenberghe R, Wallin A, Bjerke M, Zetterberg H, Blennow K, De Strooper B (2013) Reduced expression of hsa-miR-27a-3p in CSF of patients with Alzheimer disease. Neurology 81, 2103-2106.
112. Crews L, Masliah E (2010) Molecular mechanisms of neurodegeneration in Alzheimer's disease. Hum Mol Genet 19, R12-R20.
113. Vo N, Klein ME, Varlamova O, Keller DM, Yamamoto T, Goodman RH, Impey S (2005) A cAMP-response element binding protein-induced microRNAregulates neuronal morphogenesis. Proc Natl Acad Sci USA 102, 16426-16431.
114. Wayman GA, Davare M, Ando H, Fortin D, Varlamova O, Cheng HY, Marks D, Obrietan K, Soderling TR, Goodman RH, Impey S (2008) An activity-regulated microRNA controls dendritic plasticity by down-regulating p250GAP. Proc Natl Acad Sci USA 105, 9093-9098.
115. Schratt GM, Tuebing F, Nigh EA, Kane CG, Sabatini ME, Kiebler M, Greenberg ME (2006) A brain-specific microRNA regulates dendritic spine development. Nature 439, 283-289.
116. Dhahbi JM, Spindler SR, Atamna H, Yamakawa A, Guerrero N, Boffelli D, Mote P, Martin DI (2013) Deep sequencing identifies circulating mouse miRNAs that are functionally implicated in manifestations of aging and responsive to calorie restriction. Aging (Albany NY) 5, 130-141.
117. Alexandrov PN, Dua P, Hill JM, Bhattacharjee S, Zhao Y, Lukiw WJ (2012) microRNA (miRNA) speciation in Alzheimer's disease (AD) cerebrospinal fluid (CSF) and extracellular fluid (ECF). Int J Biochem Mol Biol 3, 365-373.
118. Lukiw WJ (2012) NF-small ka, CyrillicB-regulated micro RNAs (miRNAs) in primary human brain cells. Exp Neurol 235, 484-490.
119. Fu Y, Zhao D, Yang L (2014) Protein-based biomarkers in cerebrospinal fluid and blood for Alzheimer's disease. J Mol Neurosci 54, 739-747.
120. Hebert SS, Papadopoulou AS, Smith P, Galas MC, Planel E, Silahtaroglu AN, Sergeant N, Buee L, De Strooper B (2010) Genetic ablation of Dicer in adult forebrain neurons results in abnormal tau hyperphosphorylation and neurodegeneration. Hum Mol Genet 19, 3959-3969.
121. Nelson PT, Wang WX (2010) MiR-107 is reduced in Alzheimer's disease brain neocortex: Validation study. J Alzheimers Dis 21, 75-79.
122. Zhu HC, Wang LM, Wang M, Song B, Tan S, Teng JF, Duan DX (2012) MicroRNA-195 downregulates Alzheimer's disease amyloid-beta production by targetingBACE1. Brain Res Bull 88, 596-601.
123. Zhang R, Zhang Q, Niu J, Lu K, Xie B, Cui D, Xu S (2014) Screening of microRNAs associated with Alzheimer's disease using oxidative stress cell model and different strains of senescence accelerated mice. J Neurol Sci 338, 57-64.
124. Schonrock N, Ke YD, Humphreys D, Staufenbiel M, Ittner LM, Preiss T, Gotz J (2010) Neuronal microRNA deregulation in response to Alzheimer's disease amyloid-beta. PLoS One 5, e11070.
125. Vilardo E, Barbato C, Ciotti M, Cogoni C, Ruberti F (2010) MicroRNA-101 regulates amyloid precursor protein expression in hippocampal neurons. J Biol Chem 285, 18344-18351.
126. Patel N, Hoang D, Miller N, Ansaloni S, Huang Q, Rogers JT, Lee JC, Saunders AJ (2008) MicroRNAs can regulate human APP levels. Mol Neurodegener 3, 10.
127. Muller M, Kuiperij HB, Claassen JA, Kusters B, Verbeek MM (2014) MicroRNAs in Alzheimer's disease: Differential expression in hippocampus and cell-free cerebrospinal fluid. Neurobiol Aging 35, 152-158.
128. Lei X, Lei L, Zhang Z, Zhang Z, Cheng Y(2015) Downregulated miR-29c correlates with increased BACE1 expression in sporadic Alzheimer's disease. Int J Clin Exp Pathol 8, 1565-1574.
129. Barak B, Shvarts-Serebro I, Modai S, Gilam A, Okun E, Michaelson DM, Mattson MP, Shomron N, Ashery U (2013) Opposing actions of environmental enrichment and Alzheimer's disease on the expression of hippocampal microRNAs in mouse models. Transl Psychiatry 3, e304.
130. Pogue AI, Cui JG, Li YY, Zhao Y, Culicchia F, Lukiw WJ (2010) Micro RNA-125b (miRNA-125b) function in astrogliosis and glial cell proliferation. Neurosci Lett 476, 18-22.
131. Li YY, Cui JG, Hill JM, Bhattacharjee S, Zhao Y, Lukiw WJ (2011) Increased expression of miRNA-146a in Alzheimer's disease transgenic mouse models. Neurosci Lett 487, 94-98.
132. Holohan KN, Lahiri DK, Schneider BP, Foroud T, Saykin AJ (2012) Functional microRNAs in Alzheimer's disease and cancer: Differential regulation of common mechanisms and pathways. Front Genet 3, 323.
133. KimW, Noh H, Lee Y, Jeon J, Shanmugavadivu A, McPhie DL, Kim KS, Cohen BM, Seo H, Sonntag KC (2014) MiR-126 regulates growth factor activities and vulnerability to toxic insult in neurons. Mol Neurobiol. doi: 10.1007/s12035-014-8989-x
134. Absalon S, Kochanek DM, Raghavan V, Krichevsky AM (2013) MiR-26b, upregulated in Alzheimer's disease, activates cell cycle entry, tau-phosphorylation, and apoptosis in postmitotic neurons. J Neurosci 33, 14645-14659.